1Skoutelis AT,Kaleridis VE,Goumenos DS,et al.Polymorphonuclear leukocyte rigidity is defective in patients with chronic renal failure.Nephrol Dial Transplant,2000,15(11):1788-1793
2Preston GA,Barrett CV,Alcorta DA,et al.Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels.Nephron,2002,92(4):817-823
3Borazan A,Ustun H,Yilmaz A.The effects of haemodialysis and peritoneal dialysis on serum lipoprotein(a) and Creactive protein levels.J Int Med Res,2003,31(5):378-383
4Zoccali C,Benedetto FA,Mallamaci F,et al.Inflammation is associated with carotid atherosclerosis in dialysis patients.J Hypertens,2000,18(9):1207-1213
5Danielski M,Ikizler TA,McMonagle E,et al.Linkage of hypoalbuminemia,inflammation,and oxidative stress in patients receiving maintenance hemodialysis therapy.Am J Kidney Dis,2003,42(2):286-294
6Bolton CH,Downs LG,Victory JG,et al.Endothelial dysfunction in chronic renal failure:roles of lipoprotein oxidation and pro-inflammatory cytokines.Nephrol Dial Transplant,2001,16(6):1189-1197
8Aguilera A,Codoceo R,Selgas R,et al.Anorexigen (TNF-alpha,cholccystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients:their relationship with nutritional parameters.Nephrol Dial Transplant,1998,13(6),1476-1483
9Miyata T,Iida Y,Ueda Y,et al.Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products.Kidney Int,1996,49(2):538-550
10Panichi V,Migliori M,De Pietro S,et al.C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure.Nephron,2002,91(4):594-600
